Daohong Zhou

Dr. Zhou is a Professor of Pharmacodynamics at the College of Pharmacy at the University of Florida. He serves as the Associate Director for Translation and Drug Development and the Harry E. Innes Professorship of Cancer Research at the UF Health Cancer Center. Dr. Zhou has published more than 110 peer reviewed scientific articles and book chapters and co- invented more than 8 patents pending in the last five years. His research has been continuously funded for almost two decades by the National Cancer Institute and the National Institute of Allergy and Infectious Disease. He also co-founded Unity Biotechnology (NASDAQ UBX) to develop senolytic drugs for aging and age-related diseases.